Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2011 | 1 |
2013 | 1 |
2014 | 1 |
2017 | 1 |
2018 | 1 |
2019 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Optimization of HER3 expression imaging using affibody molecules: Influence of chelator for labeling with indium-111.
Sci Rep. 2019 Jan 24;9(1):655. doi: 10.1038/s41598-018-36827-w.
Sci Rep. 2019.
PMID: 30679757
Free PMC article.
Anti-LRP5/6 VHHs promote differentiation of Wnt-hypersensitive intestinal stem cells.
Fenderico N, van Scherpenzeel RC, Goldflam M, Proverbio D, Jordens I, Kralj T, Stryeck S, Bass TZ, Hermans G, Ullman C, Aastrup T, Gros P, Maurice MM.
Fenderico N, et al. Among authors: bass tz.
Nat Commun. 2019 Jan 21;10(1):365. doi: 10.1038/s41467-018-08172-z.
Nat Commun. 2019.
PMID: 30664649
Free PMC article.
Item in Clipboard
Evaluation of the Therapeutic Potential of a HER3-Binding Affibody Construct TAM-HER3 in Comparison with a Monoclonal Antibody, Seribantumab.
Orlova A, Bass TZ, Rinne SS, Leitao CD, Rosestedt M, Atterby C, Gudmundsdotter L, Frejd FY, Löfblom J, Tolmachev V, Ståhl S.
Orlova A, et al. Among authors: bass tz.
Mol Pharm. 2018 Aug 6;15(8):3394-3403. doi: 10.1021/acs.molpharmaceut.8b00393. Epub 2018 Jul 25.
Mol Pharm. 2018.
PMID: 29995421
Item in Clipboard
In vivo evaluation of a novel format of a bivalent HER3-targeting and albumin-binding therapeutic affibody construct.
Bass TZ, Rosestedt M, Mitran B, Frejd FY, Löfblom J, Tolmachev V, Ståhl S, Orlova A.
Bass TZ, et al.
Sci Rep. 2017 Feb 23;7:43118. doi: 10.1038/srep43118.
Sci Rep. 2017.
PMID: 28230065
Free PMC article.
Item in Clipboard
Engineering of a bispecific affibody molecule towards HER2 and HER3 by addition of an albumin-binding domain allows for affinity purification and in vivo half-life extension.
Malm M, Bass T, Gudmundsdotter L, Lord M, Frejd FY, Ståhl S, Löfblom J.
Malm M, et al. Among authors: bass t.
Biotechnol J. 2014 Sep;9(9):1215-22. doi: 10.1002/biot.201400009. Epub 2014 Apr 23.
Biotechnol J. 2014.
PMID: 24678002
Item in Clipboard
Inhibiting HER3-mediated tumor cell growth with affibody molecules engineered to low picomolar affinity by position-directed error-prone PCR-like diversification.
Malm M, Kronqvist N, Lindberg H, Gudmundsdotter L, Bass T, Frejd FY, Höidén-Guthenberg I, Varasteh Z, Orlova A, Tolmachev V, Ståhl S, Löfblom J.
Malm M, et al. Among authors: bass t.
PLoS One. 2013 May 10;8(5):e62791. doi: 10.1371/journal.pone.0062791. Print 2013.
PLoS One. 2013.
PMID: 23675426
Free PMC article.
Item in Clipboard
A lateral flow protein microarray for rapid and sensitive antibody assays.
Gantelius J, Bass T, Sjöberg R, Nilsson P, Andersson-Svahn H.
Gantelius J, et al. Among authors: bass t.
Int J Mol Sci. 2011;12(11):7748-59. doi: 10.3390/ijms12117748. Epub 2011 Nov 9.
Int J Mol Sci. 2011.
PMID: 22174629
Free PMC article.
Item in Clipboard
Cite
Cite